Extract
The psychological effects of the coronavirus 2019 (COVID-19) lockdown and fear of aerosolisation made us think that adherence to continuous positive airway pressure (CPAP) treatment might be reduced and consequently the morbidity and mortality of vulnerable obstructive sleep apnoea (OSA) patients increased.
Abstract
In a large prospective cohort of sleep apnoea patients treated by CPAP, adherence to CPAP was significantly increased during the COVID-19 lockdown. This was associated with a shift of patients considered as low adherers to average or high adherers. https://bit.ly/3cBBOhs
Footnotes
Conflict of interest: D. Attias has nothing to disclose
Conflict of interest: J.L. Pépin reports grants, personal fees and other from Air Liquide Foundation, Agiradom, AstraZeneca, Philips and Resmed, grants and other from Fisher and Paykel, Mutualia and Vitalaire, personal fees from Boehringer Ingelheim, Jazz Pharmaceutical, Night Balance and Sefam, outside the submitted work.
Conflict of interest: A. Pathak has nothing to disclose.
- Received May 5, 2020.
- Accepted May 10, 2020.
- Copyright ©ERS 2020
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
